<p>Competition ELISA using various mAbs and sera to block binding of biotinylated (bio) 2G12 (A, C) and b12 (B, D) to immobilized JR-CSF gp120. Two normal rabbit sera are used as non-immune controls. The results shown are representative of three independent experiments. The dashed horizontal line (—) corresponds to the half-maximal signal (EC50). HIVIG: HIV immune globulin provided by J. Mascola (VRC); DEN3: a mAb to dengue virus envelope provided by D. Burton (TSRI).</p
<p>(<b>A</b>) Immunization scheme. Rabbits were primed with DNA constructs expressing the full lengt...
b12, one of the few broadly neutralizing antibodies against HIV-1, binds to the CD4 binding site (CD...
We recently reported the induction of potent, cross-clade neutralizing antibodies (nAbs) against Hum...
<p>(A) Absence of blocking of neutralization by rabbit sera by the CD4 binding site scaffold RSC3. N...
<p>Rabbit immune sera collected post-3<sup>rd</sup> immunization were evaluated. Serum Ab binding ti...
The rabbit is a commonly used animal model in studying antibody responses in HIV/AIDS vaccine develo...
<p>(A) Enzyme Linked Immunosorbent Assay (ELISA) of binding of rabbit sera to modified envelope glyc...
<p>Specific antibody responses against E2 (E2wt) (A), HIV-1 Env(V3) peptide (B) and Env(gp140) (C) d...
<p>(A) End-point binding titers of rabbits immunized with either trimeric gp140 (filled squares) or ...
<p>ELISA titers of preimmune (black) and immune (red) rabbits' sera on gp120 IIIB (continuous line) ...
The rabbit is a commonly used animal model in studying antibody responses in HIV/AIDS vaccine develo...
Immune complex (IC) vaccines have been successfully used to increase immune responses against variou...
<p>(A) End-point binding titer of rabbits immunized with ITM1_4, in the presence (filled triangles) ...
Immune complex (IC) vaccines have been successfully used to increase immune responses against variou...
A fundamental challenge for developing an effective and safe HIV-1 vaccine is to identify vaccine im...
<p>(<b>A</b>) Immunization scheme. Rabbits were primed with DNA constructs expressing the full lengt...
b12, one of the few broadly neutralizing antibodies against HIV-1, binds to the CD4 binding site (CD...
We recently reported the induction of potent, cross-clade neutralizing antibodies (nAbs) against Hum...
<p>(A) Absence of blocking of neutralization by rabbit sera by the CD4 binding site scaffold RSC3. N...
<p>Rabbit immune sera collected post-3<sup>rd</sup> immunization were evaluated. Serum Ab binding ti...
The rabbit is a commonly used animal model in studying antibody responses in HIV/AIDS vaccine develo...
<p>(A) Enzyme Linked Immunosorbent Assay (ELISA) of binding of rabbit sera to modified envelope glyc...
<p>Specific antibody responses against E2 (E2wt) (A), HIV-1 Env(V3) peptide (B) and Env(gp140) (C) d...
<p>(A) End-point binding titers of rabbits immunized with either trimeric gp140 (filled squares) or ...
<p>ELISA titers of preimmune (black) and immune (red) rabbits' sera on gp120 IIIB (continuous line) ...
The rabbit is a commonly used animal model in studying antibody responses in HIV/AIDS vaccine develo...
Immune complex (IC) vaccines have been successfully used to increase immune responses against variou...
<p>(A) End-point binding titer of rabbits immunized with ITM1_4, in the presence (filled triangles) ...
Immune complex (IC) vaccines have been successfully used to increase immune responses against variou...
A fundamental challenge for developing an effective and safe HIV-1 vaccine is to identify vaccine im...
<p>(<b>A</b>) Immunization scheme. Rabbits were primed with DNA constructs expressing the full lengt...
b12, one of the few broadly neutralizing antibodies against HIV-1, binds to the CD4 binding site (CD...
We recently reported the induction of potent, cross-clade neutralizing antibodies (nAbs) against Hum...